These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 307737

  • 61. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases.
    Maddison P, Mogavero H, Provost TT, Reichlin M.
    J Rheumatol; 1979; 6(2):189-95. PubMed ID: 88520
    [Abstract] [Full Text] [Related]

  • 62. Speckled (particulate) epidermal nuclear IgG deposition in normal skin. Correlation of clinical features and laboratory findings in 46 patients with a subset of connective tissue disease characterized by antibody to extractable nuclear antigen.
    Prystowsky SD, Tuffanelli DL.
    Arch Dermatol; 1978 May; 114(5):705-10. PubMed ID: 348115
    [Abstract] [Full Text] [Related]

  • 63. Antinuclear antibodies in scleroderma, mixed connective tissue disease and "primary" Raynaud's phenomenon.
    Cruz M, Mejia G, Lavalle C, Cortes JJ, Reyes PA.
    Clin Rheumatol; 1988 Mar; 7(1):80-6. PubMed ID: 3261675
    [Abstract] [Full Text] [Related]

  • 64. [Anti-ENA antibody and nephropathy--cases of MCTD and SLE].
    Yoshida A, Shinmura I, Morozumi K, Oikawa T, Fujinami T, Matsumoto Y, Nakamura S, Gotoh I, Sohmiya S.
    Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):221-8. PubMed ID: 3488441
    [No Abstract] [Full Text] [Related]

  • 65. Human fibroblasts, a convenient nuclear substrate for detection of anti-nuclear antibodies including anti-centromere antibodies.
    Kallenberg CG, van der Meulen J, Pastoor GW, Snijder JA, Feltkamp TE, The TH.
    Scand J Rheumatol; 1983 Feb; 12(3):193-200. PubMed ID: 6414079
    [Abstract] [Full Text] [Related]

  • 66. Incidence and clinical significance of anti-ENA antibodies in systemic lupus erythematosus. Estimation by counterimmunoelectrophoresis.
    Clotet B, Guardia J, Pigrau C, Lience E, Murcia C, Pujol R, Bacardí R.
    Scand J Rheumatol; 1984 Feb; 13(1):15-20. PubMed ID: 6609426
    [Abstract] [Full Text] [Related]

  • 67. Antibodies to hn-RNP protein A1 in systemic lupus erythematosus: clinical association with Raynaud's phenomenon and esophageal dysmotility.
    Montecucco C, Caporali R, Cobianchi F, Negri C, Astaldi-Ricotti GC.
    Clin Exp Rheumatol; 1992 Feb; 10(3):223-7. PubMed ID: 1582066
    [Abstract] [Full Text] [Related]

  • 68. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
    Parker MD, Kerby GP.
    Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364
    [No Abstract] [Full Text] [Related]

  • 69. Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.
    Grennan DM, Bunn C, Hughes GR, Buchanan WW, Dick WC.
    Ann Rheum Dis; 1977 Oct; 36(5):442-7. PubMed ID: 921344
    [Abstract] [Full Text] [Related]

  • 70. [Soluble nuclear antigens and their antibodies: a new path in the immunological study of connective tissue diseases].
    Peltier AP.
    Nouv Presse Med; 1978 May 27; 7(21):1809-11. PubMed ID: 307736
    [No Abstract] [Full Text] [Related]

  • 71. Antinuclear antibodies and patterns of nuclear immunofluorescence in systemic lupus erythmatosus and other collagen vascular diseases.
    Bhuyan UN, Malaviya AN.
    Indian J Med Res; 1976 Jun 27; 64(6):895-902. PubMed ID: 789235
    [No Abstract] [Full Text] [Related]

  • 72. [Mixed connective tissue disease (Sharp's syndrome)].
    Müller W, Rosenthal M.
    Verh Dtsch Ges Inn Med; 1976 Jun 27; 83():744-50. PubMed ID: 306173
    [No Abstract] [Full Text] [Related]

  • 73. Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy.
    Sharp GC, Irvin WS, LaRoque RL, Velez C, Daly V, Kaiser AD, Holman HR.
    J Clin Invest; 1971 Feb 27; 50(2):350-9. PubMed ID: 4992992
    [Abstract] [Full Text] [Related]

  • 74. Antibody profiles of sera giving different nuclear staining patterns.
    Wangel AG, Teppo AM, Pollard A, Howarth S.
    Scand J Rheumatol; 1984 Feb 27; 13(4):303-9. PubMed ID: 6395320
    [Abstract] [Full Text] [Related]

  • 75. Clinical significance of anti-Sm antibody in systemic lupus erythematosus & related disorders.
    Singh RR, Malaviya AN, Kailash S, Varghese T.
    Indian J Med Res; 1991 Jun 27; 94():206-10. PubMed ID: 1834551
    [Abstract] [Full Text] [Related]

  • 76. [Mixed connective tissue disease and correlated diseases].
    Rebora A, Parodi A.
    G Ital Dermatol Venereol; 1990 Sep 27; 125(9):357-62. PubMed ID: 2079345
    [Abstract] [Full Text] [Related]

  • 77. [The value of RNase-ANA determinations for the diagnosis of Sharp syndrome (mixed connective tissue disease) (author's transl)].
    Rosenthal M.
    Klin Wochenschr; 1977 Jan 01; 55(1):31-5. PubMed ID: 299898
    [Abstract] [Full Text] [Related]

  • 78. Characteristics of patients with serum antibodies to extractable nuclear antigens.
    Leibfarth JH, Persellin RH.
    Arthritis Rheum; 1976 Jan 01; 19(5):851-6. PubMed ID: 786296
    [Abstract] [Full Text] [Related]

  • 79. Frequency and clinical significance of anticentromere and anti Scl-70 antibodies in an English connective tissue disease population.
    Catoggio LJ, Skinner RP, Maddison PJ.
    Rheumatol Int; 1983 Jan 01; 3(1):19-21. PubMed ID: 6412349
    [Abstract] [Full Text] [Related]

  • 80. [Immunologic background of overlap syndrome--studies on humoral immunity].
    Tojo T.
    Nihon Rinsho; 1976 Jun 01; 34(6):1178-82. PubMed ID: 787583
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.